American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | ||
| Net Income | 82,406 | 41,627 |
| Depreciation Amortization | 31,349 | 26,442 |
| Income taxes - deferred | 10,017 | -10,481 |
| Accounts receivable | -1,690 | -9,223 |
| Accounts payable and accrued liabilities | -5,326 | 8,406 |
| Other Working Capital | -9,263 | -1,291 |
| Other Operating Activity | 10,766 | 38,697 |
| Operating Cash Flow | $118,259 | $94,177 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -39,849 | -37,752 |
| Net Acquisitions | -5,086 | -12,425 |
| Investing Cash Flow | $-44,935 | $-50,177 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 33,538 | 645,636 |
| Debt Repayment | -21,302 | -425,399 |
| Common Stock Issued | 4,669 | 373 |
| Common Stock Repurchased | -48 | N/A |
| Dividend Paid | N/A | -199,684 |
| Other Financing Activity | -61,576 | -63,079 |
| Financing Cash Flow | $-44,719 | $-42,153 |
| Beginning Cash Position | 32,870 | 31,023 |
| End Cash Position | 61,475 | 32,870 |
| Net Cash Flow | $28,605 | $1,847 |
| Free Cash Flow | ||
| Operating Cash Flow | 118,259 | 94,177 |
| Capital Expenditure | -39,849 | -37,752 |
| Free Cash Flow | 78,410 | 56,425 |